Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues:    
Product revenues $ 4,416,036 $ 3,378,765
Development service revenues 37,405 103,846
Other service revenues 140,751 121,871
Total revenues 4,594,192 3,604,482
Cost of product revenues 1,987,636 1,927,138
Research and development costs 1,957,332 3,297,112
Selling, general, and administrative expenses 8,370,749 $ 8,039,455
Restructuring charges $ 1,252,584
Gain on sale of intellectual property $ (4,338,601)
Operating loss $ (8,974,109) (5,320,622)
Other income (expense):    
Gain on change in fair value of derivative liabilities $ 1,539,876 1,549,696
Gain on forgiveness of amounts in accounts payable 77,837
Other income, net $ 230,875 175,547
Interest income 16,455 11,617
Interest expense (1,262,343) (1,018,807)
Net loss $ (8,449,246) $ (4,524,732)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.11) $ (0.08)
Weighted average shares outstanding:    
Basic and diluted (in shares) 75,393,957 59,240,848